C 4 Therapeutics, Inc.

Organization

Watertown, MA, US

Ticker Symbols

NASDAQ:CCCC

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 11,992,531
- Issue date May 28, 2024
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glutarimides for medical treatment
- Patent number 11,802,131
- Issue date Oct 31, 2023
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydrobenzimidazolones for medical treatment
- Patent number 11,787,802
- Issue date Oct 17, 2023
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binders for the degradation of ikaros
- Patent number 11,753,397
- Issue date Sep 12, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for targeted degradation of BRD9
- Patent number 11,691,972
- Issue date Jul 4, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoindolinone and indazole compounds for the degradation of EGFR
- Patent number 11,673,902
- Issue date Jun 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic compounds
- Patent number 11,623,929
- Issue date Apr 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic compounds
- Patent number 11,584,748
- Issue date Feb 21, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Degraders and Degrons for targeted protein degradation
- Patent number 11,524,949
- Issue date Dec 13, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N/O-linked Degrons and Degronimers for protein degradation
- Patent number 11,459,335
- Issue date Oct 4, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic degraders of Ikaros and Aiolos
- Patent number 11,407,732
- Issue date Aug 9, 2022
- C4 Therapeutics, Inc.
- James A. Henderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydroquinolinones for medical treatment
- Patent number 11,401,256
- Issue date Aug 2, 2022
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydrobenzimidazolones for medical treatment
- Patent number 11,254,672
- Issue date Feb 22, 2022
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 11,185,592
- Issue date Nov 30, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,905,768
- Issue date Feb 2, 2021
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C3-carbon linked glutarimide degronimers for target protein degrada...
- Patent number 10,849,982
- Issue date Dec 1, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic degronimers for target protein degradation
- Patent number 10,660,968
- Issue date May 26, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic degronimers for target protein degradation
- Patent number 10,646,575
- Issue date May 12, 2020
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS
- Publication number 20240158418
- Publication date May 16, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
- Publication number 20240109889
- Publication date Apr 4, 2024
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20240076300
- Publication date Mar 7, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20240051953
- Publication date Feb 15, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY
- Publication number 20240018118
- Publication date Jan 18, 2024
- C 4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC COMPOUNDS
- Publication number 20240018156
- Publication date Jan 18, 2024
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC COMPOUNDS
- Publication number 20230416251
- Publication date Dec 28, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...
- Publication number 20230372496
- Publication date Nov 23, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20230357180
- Publication date Nov 9, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4
- Publication number 20230339902
- Publication date Oct 26, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N/O-Linked Degrons and Degronimers for Protein Degradation
- Publication number 20230279023
- Publication date Sep 7, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- G07 - CHECKING-DEVICES
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF RET
- Publication number 20230233692
- Publication date Jul 27, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADVANTAGEOUS THERAPIES FOR DISORDERS MEDIATED BY IKAROS OR AIOLOS
- Publication number 20230190760
- Publication date Jun 22, 2023
- C4 Therapeutics, Inc.
- David Proia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIHYDROQUINOLINONES FOR MEDICAL TREATMENT
- Publication number 20230192643
- Publication date Jun 22, 2023
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRAF DEGRADERS
- Publication number 20230145336
- Publication date May 11, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR
- Publication number 20230110648
- Publication date Apr 13, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230095223
- Publication date Mar 30, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC DEGRADERS OF IKAROS AND AIOLOS
- Publication number 20230082430
- Publication date Mar 16, 2023
- C4 Therapeutics, Inc.
- James A. Henderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20230060334
- Publication date Mar 2, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20230024096
- Publication date Jan 26, 2023
- HOFFMANN-LA ROCHE INC.
- Martin DUPLESSIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20230014124
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT
- Publication number 20230019060
- Publication date Jan 19, 2023
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL COMPOUNDS
- Publication number 20230002367
- Publication date Jan 5, 2023
- HOFFMANN-LA ROCHE INC.
- Delphine GAUFRETEAU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED PROTEIN DEGRADATION
- Publication number 20220372016
- Publication date Nov 24, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...
- Publication number 20220313826
- Publication date Oct 6, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
- Publication number 20220313827
- Publication date Oct 6, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT
- Publication number 20220289738
- Publication date Sep 15, 2022
- C4 Therapeutics, Inc.
- Roger Norcross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION
- Publication number 20220251061
- Publication date Aug 11, 2022
- C4 Therapeutics, Inc.
- Andrew J. Phillips
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
- Publication number 20220098194
- Publication date Mar 31, 2022
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1
- Publication number 20210198256
- Publication date Jul 1, 2021
- C4 Therapeutics, Inc.
- Christopher G. Nasveschuk
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98273584 - C4 THERAPEUTICS
- Serial number 98273584
- Filing date Nov 16, 2023
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90430623 - BIDAC
- Serial number 90430623
- Registration number 7236926
- Filing date Dec 30, 2020
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90430706 - MONODAC
- Serial number 90430706
- Registration number 7236927
- Filing date Dec 30, 2020
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90049754 - TORPEDO
- Serial number 90049754
- Registration number 6444492
- Filing date Jul 13, 2020
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90049788 - BIDAC
- Serial number 90049788
- Filing date Jul 13, 2020
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90049843 - MONODAC
- Serial number 90049843
- Filing date Jul 13, 2020
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88414984
- Serial number 88414984
- Registration number 6569784
- Filing date May 3, 2019
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88414911 - DAEDALUS
- Serial number 88414911
- Registration number 6000314
- Filing date May 3, 2019
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88210756 - DAEDALUS
- Serial number 88210756
- Registration number 5933788
- Filing date Nov 29, 2018
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87428322 - C4 PHARMACEUTICALS
- Serial number 87428322
- Filing date Apr 27, 2017
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87428289 - C4 PHARMA
- Serial number 87428289
- Filing date Apr 27, 2017
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87191939 - SMART-CAR
- Serial number 87191939
- Filing date Oct 4, 2016
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86824725 - C4 THERAPEUTICS
- Serial number 86824725
- Registration number 5312039
- Filing date Nov 18, 2015
- C4 Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86824767 - DEGRONIMID
- Serial number 86824767
- Filing date Nov 18, 2015
- C4 Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations

C 4 Therapeutics, Inc.

Organization

Ticker Symbols

Patents Grantslast 30 patents

C3-carbon linked glutarimide degronimers for target protein degrada...

Glutarimides for medical treatment

Dihydrobenzimidazolones for medical treatment

Cereblon binders for the degradation of ikaros

Compounds for targeted degradation of BRD9

Isoindolinone and indazole compounds for the degradation of EGFR

Spirocyclic compounds

Spirocyclic compounds

Degraders and Degrons for targeted protein degradation

N/O-linked Degrons and Degronimers for protein degradation

Tricyclic degraders of Ikaros and Aiolos

Dihydroquinolinones for medical treatment

Dihydrobenzimidazolones for medical treatment

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

C3-carbon linked glutarimide degronimers for target protein degrada...

Spirocyclic degronimers for target protein degradation

Heterocyclic degronimers for target protein degradation

Patents Applicationslast 30 patents

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY

SPIROCYCLIC COMPOUNDS

SPIROCYCLIC COMPOUNDS

TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED...

DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION

TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4

N/O-Linked Degrons and Degronimers for Protein Degradation

COMPOUNDS FOR TARGETED DEGRADATION OF RET

ADVANTAGEOUS THERAPIES FOR DISORDERS MEDIATED BY IKAROS OR AIOLOS

DIHYDROQUINOLINONES FOR MEDICAL TREATMENT

BRAF DEGRADERS

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

TRICYCLIC DEGRADERS OF IKAROS AND AIOLOS

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT

BIFUNCTIONAL COMPOUNDS

TARGETED PROTEIN DEGRADATION

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADA...

SUBSTITUTED PIPERIDINE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT

DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1

Trademarklast 30 trademarks

98273584 - C4 THERAPEUTICS

90430623 - BIDAC

90430706 - MONODAC

90049754 - TORPEDO

90049788 - BIDAC

90049843 - MONODAC

88414984

88414911 - DAEDALUS

88210756 - DAEDALUS

87428322 - C4 PHARMACEUTICALS

87428289 - C4 PHARMA

87191939 - SMART-CAR

86824725 - C4 THERAPEUTICS

86824767 - DEGRONIMID